Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Runnebaum

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Anticancer Research|July 1, 1997
Basics of cancer gene therapyI B Runnebaum
Hybridoma|April 1, 1995
p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapyI B Runnebaum, R Kreienberg
Journal of Cancer Research and Clinical Oncology|February 24, 2001
Epidemiological and molecular aspects of ovarian cancer riskI B Runnebaum, E Stickeler
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 21, 1999
Intrauterine resuscitation by rapid urinary bladder instillation in a case of occult prolapse of an excessively long umbilical cordI B Runnebaum, M Katz
Gene Therapy|February 7, 2003
CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbetaA Brüning, I B Runnebaum
Methods in Molecular Medicine|February 23, 2011
Multiplex PCR (MPCR) Screening Can Detect Small Intragenic p53 Deletion and Insertion MutationsI B Runnebaum, S Wang-Gohrke
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 24, 2005
[Vulvodynia]U R Hengge, I B Runnebaum
Biotechniques|October 1, 1991
Vector PCRI B Runnebaum, P Syka, S Sukumar
Journal of Cellular Biochemistry|December 1, 1995
Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53I B Runnebaum, S Wang, R Kreienberg
Journal of Cancer Research and Clinical Oncology|March 31, 2000
Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitroQ Wu, R Kreienberg, I B Runnebaum
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Anticancer Research|July 1, 1997
Basics of cancer gene therapyI B Runnebaum
Hybridoma|April 1, 1995
p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapyI B Runnebaum, R Kreienberg
Journal of Cancer Research and Clinical Oncology|February 24, 2001
Epidemiological and molecular aspects of ovarian cancer riskI B Runnebaum, E Stickeler
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 21, 1999
Intrauterine resuscitation by rapid urinary bladder instillation in a case of occult prolapse of an excessively long umbilical cordI B Runnebaum, M Katz
Gene Therapy|February 7, 2003
CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbetaA Brüning, I B Runnebaum
Methods in Molecular Medicine|February 23, 2011
Multiplex PCR (MPCR) Screening Can Detect Small Intragenic p53 Deletion and Insertion MutationsI B Runnebaum, S Wang-Gohrke
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 24, 2005
[Vulvodynia]U R Hengge, I B Runnebaum
Biotechniques|October 1, 1991
Vector PCRI B Runnebaum, P Syka, S Sukumar
Journal of Cellular Biochemistry|December 1, 1995
Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53I B Runnebaum, S Wang, R Kreienberg
Journal of Cancer Research and Clinical Oncology|March 31, 2000
Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitroQ Wu, R Kreienberg, I B Runnebaum
Pageof 8